Skip Navigation

Jay Treat

Jay Treat

Chief Manufacturing Officer
Principal Investigator
Center for Innovation in Advanced Development and Manufacturing
Texas A&M University

Expertise

Lag in biological and vaccine manufacturing

Treat is a well-recognized technical and bioprocessing leader with more than twenty-eight years of broad industrial experience and demonstrated accomplishments in biologics (recombinant proteins, monoclonal antibodies, viral vaccines and algae), diagnostics and vaccine manufacturing process development, scale-up, characterization, technology transfer, manufacturing, quality assurance and regulatory support.

He has been providing scientific excellence and strategic leadership within multifunctional CMC teams on more than 250 large molecules, peptides, MSCs, small molecules and vaccines plus more than 1,500 diagnostics including IVF. His experience in quality systems and regulatory include more than sixty-five INDs, two IDEs, more than 1,500 510Ks and numerous FDA, EMA, and ISO inspections. Manufacturing experience extends from bench scale bioreactors to 30,000L biologics to +120,000L for algae.

Prior to joining Texas A&M University as director of the National Center for Therapeutics Manufacturing, working closely with BARDA and the CIADM teams, Treat served as president and chief technology officer at Bone Biologics Corporation, chief operating officer at Avid Bioservices CDMO, where he oversaw biologic manufacturing from conception to commercial licensing of the facility.

Treat received his doctorate in agricultural and biochemical engineering from Texas A&M.